glp-1 news updates november 2025 trends 2025: real-world data, patient outcomes & future therapies GLP-1 Shortage = Over -

Our Take Built for athletes who refuse to choose between going light and going long

Lo que significa para usted: La cada del cabello es una de las preocupaciones ms emotivas que plantean los clientes, y una de las ms desatendidas en la mayora de los spas

This is why some patients experience heartburn or acid regurgitation shortly after starting semaglutide or increasing their dose

Why Sun Pharmas semaglutide approval matters in Indias weight loss drug market Besides Sun Pharma, a growing roster of Indian drugmakers is lining up cheaper generic versions of semaglutide ahead of the patent expiry in March 2026 to tap into demand Earlier today, Sun Pharmaceutical Industries said it had received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection, a glucagonlike peptide1 (GLP1) receptor agonist indicated for chronic weight management in adults

297 p53 is significantly acetylated at the Lys (118) residue in a rat model of ischemia/reperfusion injury, which regulates p53 binding and accumulation at the Bax promoter